嬌生JNJ
紐約證券 · USD
265.58
-0.77
(-0.29%)
收盤 09/12 03:59 (UTC+8)
盤後
266.05
+0.47
(+0.18%)
09/12 03:59 (UTC+8)
嬌生JNJ
265.58
-0.77
(-0.29%)
財務數據
損益表
- 213.83
- 224.47
- 224.71
- 225.20
- 218.93
- 237.43
- 239.93
- 245.64
- 240.62
- 253.10
- -0.06
- 4.98
- 0.11
- 0.22
- -2.78
- 8.45
- 1.05
- 2.38
- -2.04
- 5.19
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 25,310,000 | 24,062,000 | 24,564,000 | 23,993,000 | 23,743,000 | 21,893,000 | 22,520,000 | 22,471,000 | 22,447,000 | 21,383,000 |
營業成本 | 8,051,000 | 8,106,000 | 7,968,000 | 7,303,000 | 7,628,000 | 7,357,000 | 7,128,000 | 6,963,000 | 6,869,000 | 6,511,000 |
營業毛利 | 17,259,000 | 15,956,000 | 16,596,000 | 16,690,000 | 16,115,000 | 14,536,000 | 15,392,000 | 15,508,000 | 15,578,000 | 14,872,000 |
營業費用 | 10,119,000 | 9,629,000 | 11,170,000 | 9,657,000 | 9,469,000 | - | - | - | - | 8,963,000 |
研發費用 | 3,653,000 | 3,527,000 | 4,252,000 | 3,672,000 | 3,516,000 | 3,225,000 | 5,298,000 | 4,952,000 | 3,440,000 | 3,542,000 |
推銷及管理費用 | 6,432,000 | 6,034,000 | 6,753,000 | 5,922,000 | 5,889,000 | 5,112,000 | 6,453,000 | 5,478,000 | 5,681,000 | 5,257,000 |
非經常性項目費用 | 34,000 | 68,000 | 165,000 | 63,000 | 64,000 | 17,000 | 59,000 | 41,000 | 181,000 | 164,000 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 7,140,000 | 6,327,000 | 5,426,000 | 7,033,000 | 6,646,000 | 6,182,000 | 3,582,000 | 5,037,000 | 6,276,000 | 5,909,000 |
其他收入及費用 | -112,000 | -65,000 | -246,000 | 705,000 | 153,000 | 7,653,000 | 442,000 | -1,506,000 | -258,000 | -2,040,000 |
利息費用 | 281,000 | 272,000 | 214,000 | 245,000 | 308,000 | 204,000 | 137,000 | 193,000 | 270,000 | 155,000 |
稅前純益 | 6,747,000 | 5,990,000 | 4,966,000 | 7,493,000 | 6,491,000 | 13,631,000 | 3,887,000 | 3,338,000 | 5,748,000 | 3,714,000 |
所得稅 | 1,213,000 | 755,000 | -150,000 | 2,341,000 | 954,000 | 2,632,000 | 456,000 | 644,000 | 1,062,000 | 459,000 |
稅後純益 | 5,534,000 | 5,235,000 | 5,116,000 | 5,152,000 | 5,537,000 | 10,999,000 | 3,431,000 | 2,694,000 | 4,686,000 | 3,255,000 |
基本每股稅後盈餘(元) | 2.30 | 2.17 | 2.12 | 2.14 | 2.30 | 4.57 | 1.43 | 1.12 | 1.95 | 1.35 |
稀釋每股稅後盈餘(元) | 2.27 | 2.14 | 2.09 | 2.12 | 2.28 | 4.54 | 1.41 | 1.11 | 1.93 | 1.34 |
基本平均股數(千股) | 2408228.00 | 2408700.00 | 2407939.00 | 2408300.00 | 2406300.00 | 2405625.00 | 2406922.00 | 2407298.00 | 2406846.00 | 2408200.00 |
稀釋平均股數(千股) | 2440100.00 | 2445200.00 | 2439000.00 | 2428600.00 | 2419100.00 | 2423800.00 | 2427100.00 | 2427900.00 | 2422000.00 | 2430100.00 |
還原基本每股稅後盈餘(元) | 2.30 | 2.17 | 2.12 | 2.14 | 2.30 | 4.57 | 1.43 | 1.12 | 1.95 | 1.35 |
還原稀釋每股稅後盈餘(元) | 2.27 | 2.14 | 2.09 | 2.12 | 2.28 | 4.54 | 1.41 | 1.11 | 1.93 | 1.34 |
還原基本平均股數(千股) | 2,408,228 | 2,408,700 | 2,407,939 | 2,408,300 | 2,406,300 | 2,405,625 | 2,406,922 | 2,407,298 | 2,406,846 | 2,408,200 |
還原稀釋平均股數(千股) | 2,440,100 | 2,445,200 | 2,439,000 | 2,428,600 | 2,419,100 | 2,423,800 | 2,427,100 | 2,427,900 | 2,422,000 | 2,430,100 |
EBITDA(千元) | 8,987,000 | 8,266,000 | 7,191,000 | 9,515,000 | 8,742,000 | 15,607,000 | 5,920,000 | 5,377,000 | 7,800,000 | 5,684,000 |